Resources

In this third instalment of our Ask the Expert series, Mike explains how Catalyx keeps delivery tightly aligned with client KPIs, ensuring that every action drives tangible, data-backed outcomes.

This is Part 2 of our three-part ‘Ask the Expert’ series with Mike, Director of Sales and Delivery at Catalyx, where we uncover what makes their non-conventional outsourcing models so effective in the pharmaceutical industry.

This article is the first in a three part Ask the Expert series featuring Mike Barrett, Director of Sales and Delivery of Professional and Managed Services at Catalyx.

When evaluating your bioreactor and upstream operations, ask yourself: Is your bioreactor maximizing product output as efficiently and safely as possible? Overcome common barriers to bioreactor productivity with the Catalyx OpenBIO Bioreactor Control.

Line clearance remains one of the biggest bottlenecks in pharma manufacturing. Catalyx’s latest benchmark findings uncover how far the sector has come since 2023, and where manual processes are still holding production back.

Life sciences firms are rethinking how they scale, retain, and manage talent. Our 2025 survey uncovers the trends shaping smarter, more compliant, and more resilient workforce models.

Machine vision is entering a new era. In 2026, smarter sensors, edge AI, and self-healing algorithms are transforming how factories see and respond to the world. Learn what makes tomorrow’s vision systems truly intelligent, adaptable, reliable, and built to keep improving long after deployment.

As personalized medicine reshapes the pharma landscape, automation must evolve. Discover how Catalyx is redefining packaging for Cell & Gene Therapy, Biologics, mRNA, and Radiopharma with flexible, precise, and compliant solutions built for the future of individualized therapeutics.